home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Duplicitous Role for Classic Cancer Molecule

  November, 14 2008 5:02
your information resource in human molecular genetics
A molecule previously thought to promote cancer may in some circumstances play a part in slowing it down, according to research published online in Nature. The findings reveal that the biology of this system is much more complicated than originally thought.

Vascular endothelial growth factor (VEGF) is a molecule that helps cancer to grow its own blood supply and it has been linked to cancer progression. Randall Johnson and colleagues deleted VEGF production in certain cell types but not others. Unexpectedly, they find that this deletion actually accelerates rather than slows tumour growth in mice. This is in contrast with tumours that lack VEGF altogether, which grow more slowly without a blood supply. The findings reveal the importance of these cell types in regulating the tumour blood vessel network and controlling tumour growth.

In a related paper, David Cheresh and colleagues find that VEGF specifically inhibits the stabilisation of blood vessels as they grow. Together, the research demonstrates the complex role of VEGF in orchestrating blood vessel formation. The implications of this work for therapies that target VEGF are not known, although they have already proven successful in many cases.

Author contact:

Randall Johnson (University of California, La Jolla, CA, USA) Author paper 1
E-mail: rsjohnson@ucsd.edu
[Click here for abstract.]

David Cheresh (University of California at San Diego, La Jolla, CA, USA) Author paper 2
E-mail: dcheresh@ucsd.edu
[Click here for abstract.]

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.